Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease

References

• Weibel ER. Morphometry of the human lung. Berlin: Springer-Verlag; 1963.
   Google Scholar
• Baraldo S, Saetta M, Cosio MG. Pathophysiology of the small airways. Semin Respir Crit Care Med. 2003;24:465–72.
   PubMed Web of Science ®Google Scholar
• Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol. 1967;22:395–401.
   PubMed Web of Science ®Google Scholar
• Mead J. The lung's ‘quiet zone’. N Engl J Med. 1970; 282:1318–9.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Against the Dutch hypothesis: asthma and chronic obstructive pulmonary disease are distinct diseases. Am J Respir Crit Care Med. 2006;174:240–3.
   PubMed Web of Science ®Google Scholar
• Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, . Inflammation of small airways in asthma. J Allergy Clin Immunol. 1997;100:44–51.
   PubMed Web of Science ®Google Scholar
• Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, . The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645–53.
   PubMed Web of Science ®Google Scholar
• Contoli M, Bousquet J, Fabbri LM, Magnussen H, Rabe KF, Siafakas NM, . The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy. 2010;65:141–51.
   PubMed Web of Science ®Google Scholar
• Gelfand EW, Kraft M. The importance and features of the distal airways in children and adults. J Allergy Clin Immunol. 2009;124:S84–7.
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis. 1991;143:138–43.
   PubMed Web of Science ®Google Scholar
• Dolhnikoff M, da Silva LF, de Araujo BB, Gomes HA, Fernezlian S, Mulder A, . The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol. 2009;123:1090–7.
   Google Scholar
• Shiang C, Mauad T, Senhorini A, de Araújo BB, Ferreira DS, da Silva LF, . Pulmonary periarterial inflammation in fatal asthma. Clin Exp Allergy. 2009;39:1499–507.
   PubMedGoogle Scholar
• Mauad T, Silva LF, Santos MA, Grinberg L, Bernardi FD, Martins MA, . Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med. 2004;170:857–62.
   PubMed Web of Science ®Google Scholar
• Saetta M, Ghezzo H, Kim WD, King M, Angus GE, Wang NS, . Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. Am Rev Respir Dis. 1985;132:894–900.
   PubMed Web of Science ®Google Scholar
• Lams BE, Sousa AR, Rees PJ, Lee TH. Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J. 2000;15:512–6.
   PubMed Web of Science ®Google Scholar
• Battaglia S, Mauad T, van Schadewijk AM, Vignola AM, Rabe KF, Bellia V, . Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol. 2007;60:907–11.
   Google Scholar
• Haley KJ, Sunday ME, Wiggs BR, Kozakewich HP, Reilly JJ, Mentzer SJ, . Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med. 1998; 158:565–72.
   PubMed Web of Science ®Google Scholar
• Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J. 1997;10:292–300.
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, . CD8+T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822–6.
   PubMed Web of Science ®Google Scholar
• Saetta M, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S, . Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;165:1404–9.
   PubMed Web of Science ®Google Scholar
• King GG, Salome CM. Multimodality measurements of small airways disease. Eur Respir J. 2006;27:250–2.
   Google Scholar
• Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154:1505–10.
   PubMed Web of Science ®Google Scholar
• Balzar S, Wenzel SE, Chu HW. Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J. 2002;20:254–9.
   Google Scholar
• Marshall BG, Wangoo A, Harrison LI, Young DB, Shaw RJ. Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid. Eur Respir J. 2000;15:764–70.
   Google Scholar
• Hargreave FE. Induced sputum for the investigation of airway inflammation: evidence for its clinical application. Can Respir J. 1999;6:169–74.
   Google Scholar
• Ueda T, Niimi A, Matsumoto H, Takemura M, Hirai T, Yamaguchi M, . Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol. 2006;118:1019–25.
   PubMed Web of Science ®Google Scholar
• Abbott GF, Rosado-de-Christenson ML, Rossi SE, Suster S. Imaging of small airways disease. J Thorac Imaging. 2009; 24:285–98.
   Google Scholar
• Tashkin DP, de Lange EE. Imaging of the distal airways. J Allergy Clin Immunol. 2009;124:S78–83.
   Google Scholar
• Samee S, Altes T, Powers P, de Lange EE, Knight-Scott J, Rakes G, . Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol. 2003;111:1205–11.
   PubMed Web of Science ®Google Scholar
• de Lange EE, Altes TA, Patrie JT, Gaare JD, Knake JJ, Mugler JP 3rd, . Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest. 2006;130:1055–62.
   PubMed Web of Science ®Google Scholar
• van Beek EJ, Dahmen AM, Stavngaard T, Gast KK, Heussel CP, Krummenauer F, . Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J. 2009;34:1311–21.
   Google Scholar
• Jang YM, Oh YM, Seo JB, Kim N, Chae EJ, Lee YK, . Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol. 2008;43:403–10.
   PubMed Web of Science ®Google Scholar
• Musch G, Venegas JG. Positron emission tomography imaging of regional pulmonary perfusion and ventilation. Proc Am Thorac Soc. 2005;2:522–7.
   Google Scholar
• De Backer JW, Vos WG, Vinchurkar SC, Claes R, Drollmann A, Wulfrank D, . Validation of computational fluid dynamics in CT-based airway models with SPECT/CT. Radiology. 2010;257:854–62.
   PubMed Web of Science ®Google Scholar
• Goldin JG. Imaging the lungs in patients with pulmonary emphysema. J Thorac Imaging. 2009;24:163–70.
   Google Scholar
• Awadh N, Müller NL, Park CS, Abboud RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax. 1998;53:248–53.
   PubMed Web of Science ®Google Scholar
• Park CS, Müller NL, Worthy SA, Kim JS, Awadh N, Fitzgerald M. Airway obstruction in asthmatic and healthy individuals: inspiratory and expiratory thin-section CT findings. Radiology. 1997;203:361–7.
   PubMed Web of Science ®Google Scholar
• Mitsunobu F, Ashida K, Hosaki Y, Tsugeno H, Okamoto M, Nishida N, . Decreased computed tomographic lung density during exacerbation of asthma. Eur Respir J. 2003; 22:106–12.
   PubMed Web of Science ®Google Scholar
• Akira M, Toyokawa K, Inoue Y, Arai T. Quantitative CT in chronic obstructive pulmonary disease: inspiratory and expiratory assessment. Am J Roentgenol. 2009;192:267–72.
   PubMed Web of Science ®Google Scholar
• Laurent F, Latrabe V, Raherison C, Marthan R, Tunon-de-Lara JM. Functional significance of air trapping detected in moderate asthma. Eur Radiol. 2000;10:1404–10.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Watanabe N, Nakajima Y. Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. AJR Am J Roentgenol. 2008;190:762–9.
   PubMed Web of Science ®Google Scholar
• Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW, . Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol. 1999;104:S258–67.
   PubMed Web of Science ®Google Scholar
• Tunon-de-Lara JM, Laurent F, Giraud V, Perez T, Aguilaniu B, Meziane H, . Air trapping in mild and moderate asthma: effect of inhaled corticosteroids. J Allergy Clin Immunol. 2007;119:583–90.
   PubMed Web of Science ®Google Scholar
• van Beek EJ, Wild JM. Hyperpolarized 3-helium magnetic resonance imaging to probe lung function. Proc Am Thorac Soc. 2005;2:528–32.
   Google Scholar
• Peces-Barba G, Ruiz-Cabello J, Cremillieux Y, Rodríguez I, Dupuich D, Callot V, . Helium-3 MRI diffusion coefficient: correlation to morphometry in a model of mild emphysema. Eur Respir J. 2003;22:14–19.
   Google Scholar
• Woods JC, Choong CK, Yablonskiy DA, Bentley J, Wong J, Pierce JA, . Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med. 2006; 56:1293–300.
   PubMed Web of Science ®Google Scholar
• Fain SB, Panth SR, Evans MD, Wentland AL, Holmes JH, Korosec FR, . Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology. 2006;239:875–83.
   PubMed Web of Science ®Google Scholar
• Wang C, Altes TA, Mugler JP 3rd, Miller GW, Ruppert K, Mata JF, . Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD. J Magn Reson Imaging. 2008; 28:80–8.
   PubMed Web of Science ®Google Scholar
• Pride NB. Tests of forced expiration and inspiration. Clin Chest Med. 2001;22:599–622.
   PubMed Web of Science ®Google Scholar
• Scichilone N, Battaglia S, Olivieri D, Bellia V. The role of small airways in monitoring the response to asthma treatment: what is beyond FEV1? Allergy. 2009;64:1563–9.
   Google Scholar
• Lung function testing: selection of reference values and interpretive strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202–18.
   PubMed Web of Science ®Google Scholar
• Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest. 2006;129:369–77.
   PubMed Web of Science ®Google Scholar
• Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J. 1995;8:492–506.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD. 2006;3: 219–32.
   PubMedGoogle Scholar
• Lougheed MD, Fisher T, O'Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest. 2006;130:1072–81.
   PubMed Web of Science ®Google Scholar
• Mahut B, Bokov P, Delclaux C. Abnormalities of plethysmographic lung volumes in asthmatic children. Respir Med. 2010;104:966–71.
   PubMed Web of Science ®Google Scholar
• Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, . National Heart, Lung, and Blood Institute Severe Asthma Research Program. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol. 2008;104:394–403.
   PubMed Web of Science ®Google Scholar
• Drummond GB, Milic-Emili J. Forty years of closing volume. Br J Anaesth. 2007;99:772–4.
   Google Scholar
• in ‘t Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med. 2000;161:1902–6.
   PubMed Web of Science ®Google Scholar
• Bourdin A, Paganin F, Préfaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy. 2006;61:85–9.
   PubMed Web of Science ®Google Scholar
• O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, Ofir D. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax. 2009;64:216–23.
   PubMed Web of Science ®Google Scholar
• Woolcock AJ, Vincent NJ, Macklem PT. Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest. 1969;48:1097–106.
   PubMed Web of Science ®Google Scholar
• Evans DJ, Green M. Small airways: a time to revisit? Thorax. 1998;53:629–30.
   PubMedGoogle Scholar
• Buist AS. Current status of small airways disease. Chest. 1984;86:100–5.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, . Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010;138:682–92.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–30.
   PubMed Web of Science ®Google Scholar
• Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol. 1998;85:653–66.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Järvenpää R, Koivula T, . Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med. 2001;163: 1557–61.
   PubMed Web of Science ®Google Scholar
• Gelb AF, George SC, Silkoff PE, Krishnan A, Fraser C, Taylor CF, . Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma. Thorax. 2010;65: 619–25.
   PubMed Web of Science ®Google Scholar
• Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, . Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005;25:986–91.
   PubMed Web of Science ®Google Scholar
• van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J. 2006; 27:951–6.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Flynn Taylor C, Krishnan A, Fraser C, Shinar CM, Schein MJ, . Central and peripheral airway sites of nitric oxide gas exchange in COPD. Chest. 2010;137:575–84.
   PubMed Web of Science ®Google Scholar
• Van Muylem A, Kerckx Y, Michils A. Acinar effect of inhaled steroids evidenced by exhaled nitric oxide. J Allergy Clin Immunol. 2010;126:730–5.
   Google Scholar
• Downie SR, Salome CM, Verbanck S, Thompson B, Berend N, King GG. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax. 2007;62:684–9.
   PubMed Web of Science ®Google Scholar
• Crawford AB, Makowska M, Paiva M, Engel LA. Convection-and diffusion-dependent ventilation maldistribution in normal subjects. J Appl Physiol. 1985;59:838–46.
   PubMed Web of Science ®Google Scholar
• Verbanck S, Schuermans D, Noppen M, Van Muylem A, Paiva M, Vincken W. Evidence of acinar airway involvement in asthma. Am J Respir Crit Care Med. 1999;159:1545–50.
   PubMed Web of Science ®Google Scholar
• Verbanck S, Schuermans D, Van Muylem A, Melot C, Noppen M, Vincken W, . Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. Am J Respir Crit Care Med. 1998;157:1573–7.
   PubMed Web of Science ®Google Scholar
• Verbanck S, Schuermans D, Paiva M, Vincken W. Nonreversible conductive airway ventilation heterogeneity in mild asthma. J Appl Physiol. 2003;94:1380–6.
   Web of Science ®Google Scholar
• Verbanck S, Schuermans D, Vincken W. Inflammation and airway function in the lung periphery of patients with stable asthma. J Allergy Clin Immunol. 2010;125:611–6.
   PubMed Web of Science ®Google Scholar
• Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med. 2006;174:853–7.
   PubMed Web of Science ®Google Scholar
• Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol. 2005;148:179–94.
   PubMed Web of Science ®Google Scholar
• Van Noord JA, Smeets J, Clément J, Van de Woestijne KP, Demedts M. Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med. 1994;150:551–4.
   Google Scholar
• Paredi P, Goldman M, Alamen A, Ausin P, Usmani OS, Pride NB, . Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease. Thorax. 2010;65:263–7.
   PubMed Web of Science ®Google Scholar
• Muskulus M, Slats AM, Sterk PJ, Verduyn-Lunel S. Fluctuations and determinism of respiratory impedance in asthma and chronic obstructive pulmonary disease. J Appl Physiol. 2010;109:1582–91.
   PubMed Web of Science ®Google Scholar
• Melchor R, Biddiscombe MF, Mak VH, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax. 1993;48:506–11.
   PubMed Web of Science ®Google Scholar
• Pritchard JN. The influence of lung deposition on clinical response. J Aerosol Med. 2001;14:S19–26.
   PubMedGoogle Scholar
• Global Initiative for Asthma (GINA). 2008. Available at: http://www.ginasthma.org/ (accessed 13 December 2010).
   Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Taylor CF, Nussbaum E, Guitierrez C, Schein A, Shinar CM, . Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med. 2004;170:737–41.
   PubMed Web of Science ®Google Scholar
• Gelb AF, Taylor CF, Shinar CM, Gutierrez CA, Zamel N. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients. Can Respir J. 2008;15:193–8.
   PubMedGoogle Scholar
• Fritscher LG, Rodrigues MT, Zamel N, Chapman KR. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. Respir Med. 2009;103:296–300.
   PubMed Web of Science ®Google Scholar
• Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of β2-agonist particle size. Am J Respir Crit Care Med. 2005; 172:1497–504.
   PubMed Web of Science ®Google Scholar
• Newman S, Salmon A, Nave R, Drollmann A. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med. 2006; 100:375–84.
   PubMed Web of Science ®Google Scholar
• Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122:510–6.
   PubMed Web of Science ®Google Scholar
• Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, . Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol. 1999;104:1215–22.
   PubMed Web of Science ®Google Scholar
• De Backer W, Devolder A, Poli G, Acerbi D, Monno R, Herpich C, . Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv. 2010;23:137–48.
   PubMed Web of Science ®Google Scholar
• Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J. 2007;29: 682–9.
   PubMed Web of Science ®Google Scholar
• Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy. 2007; 62:1182–8.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Niimi A, Ueda T, Takemura M, Matsuoka H, Jinnai M, . Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther. 2009;22:326–32.
   PubMed Web of Science ®Google Scholar
• Hoshino M. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma. Allergol Int. 2010;59:59–66.
   PubMedGoogle Scholar
• Verbanck S, Schuermans D, Paiva M, Vincken W. The functional benefit of anti-inflammatory aerosols in the lung periphery. J Allergy Clin Immunol. 2006;118:340–6.
   Google Scholar
• Cohen J, Douma WR, ten Hacken NH, Vonk JM, Oudkerk M, Postma D. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J. 2008;31: 1213–20.
   PubMed Web of Science ®Google Scholar
• Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J. 2001;18: 635–9.
   PubMed Web of Science ®Google Scholar
• Zierenberg B. Optimizing the in vitro performance of Respimat. J Aerosol Med. 1999;1:S19–24.
   Google Scholar
• Newman SP, Brown J, Steed SP, Reader SJ, Kladders H. Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines. Chest. 1998;113:957–63.
   PubMed Web of Science ®Google Scholar
• Pitcairn G, Reader R, Pavia D, Newman S. Deposition of corticosteroid aerosol in the human lung by Respimat® Soft Mist™ Inhaler compared to deposition by metered dose inhaler or by Turbuhaler® dry powder inhaler. J Aerosol Med. 2005;18:264–72.
   PubMedGoogle Scholar
• Brand P, Hederer B, Austen G, Dewberry H, Meyer T. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique. Int J Chron Obstruct Pulmon Dis. 2008;3:763–70.
   PubMedGoogle Scholar
• Brand P, Meyer T, Weuthen T, Timmer W, Berkel E, Wallenstein G, . Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease. J Clin Pharmacol. 2007;47:1335–41.
   PubMed Web of Science ®Google Scholar
• Ichinose M, Fujimoto T, Fukuchi Y. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med. 2010;104: 228–36.
   PubMed Web of Science ®Google Scholar
• Michele TM, Pinheiro S, Iyasu S. The safety of tiotropium—the FDA's conclusions. N Engl J Med. 2010;363:1097–9.
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543–54.
   PubMed Web of Science ®Google Scholar